NCT07077057Recruiting
Ticino Artificial InTelligence integrAtioN for Occlusion Myocardial Infarction
Source: ClinicalTrials.gov · Last updated 5 May 2026
Brief summary (registry, in English)
The goal of this clinical trial is to evaluate whether an artificial intelligence (AI)-based ECG interpretation tool improves the early diagnosis and treatment of occlusion myocardial infarction (OMI) in adults presenting with suspected acute coronary syndrome (ACS) who do not meet traditional ST-elevation myocardial infarction (STEMI) criteria. The main questions it aims to answer are: 1. Does AI-assisted ECG interpretation enable more timely identification and treatment of OMI, as defined by earlier initiation of coronary intervention? 2. Does AI-assisted diagnosis reduce infarct size, measured by peak high-sensitivity troponin T (hsTnT) levels? Researchers will compare AI-assisted ECG interpretation to standard care to determine if the AI tool improves clinical outcomes and care timelines. Participants will: 1. Present with symptoms suggestive of ACS but without clear STEMI criteria 2. Be randomized 1:1 to either AI-assisted or standard ECG interpretation 3. Undergo follow-up assessments for cardiovascular outcomes, including 30-day death, time to treatment of total coronary occlusion, and peak hsTnT levels
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- First submitted
- 1 Jul 2025
- Start date
- 23 Aug 2025
- Primary completion date
- Aug 2027
- Lead sponsor
- Cardiocentro Ticino
- Diseases
- Coronary artery disease
- NCT number
- NCT07077057
What you commit to
- Study type: Interventional
- Planned participants: 500
- From 23 Aug 2025 to the primary completion date, Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Symptoms onset\>24 hrs prior to clinical presentation.
Other
- Clear diagnosis of ST-segment elevation MI (STEMI) according to managing physicians.
- Pregnancy or Lactation.
- Legally incompetent to provide informed consent.
Who the study is looking for
- Symptoms suspected of ongoing acute myocardial ischemia: Patients presenting with symptoms such as chest pain, dyspnoea, sweating, nausea or vomiting, pain radiating to the shoulder/arm/jaw/back, fatigue, or light-headedness
- Age: Patients aged 18 years or older.
- Informed Consent: Patients able to provide informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cardiocentro Ticino Institute Coordinator of this site? Confirm its status | Lugano | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.